Americans Are Dangerously Dependent on Foreign-made Generic Drugs. Tariffs Can Fix That.
Tariffs on pharmaceutical companies isn’t just good economic policy — it benefits national security and public health.
Imports Show Near-Zero Growth Month Over Month As Tariff Reset Begins
Imports did not vanish, but their growth rate was flat at zero percent in February compared to January after nearly two months of importers rushing in orders ahead of tariffs. February goods and services imports were $401 billion, a statistically insignificant change from January, the Bureau of Economic Analysis said.
CPA Supports Senator Rick Scott’s Legislative Package to Protect American Investors from Chinese Exploitation
This legislative initiative aligns with CPA’s commitment to ensuring that U.S. capital does not inadvertently support adversarial regimes that undermine America’s economic and national security interests.
What Members of the House Ways and Means Committee Are Saying About Tariffs
Members of the House Ways and Means Committee gave U.S. Trade Representative Jamieson Greer a piece of their mind on Wednesday during a four-and-a-half-hour hearing—double the time he spent with the Senate Finance Committee the day before.
Is China Gaining Ground in the New Space Race?
Is China a peer competitor in the space race? On some fronts, the answer is yes. In others, the concern is that China is moving up the value chain so quickly that its companies may soon out-price American firms across the developing world.
USTR Jamieson Greer Tells Senate: Trump Tariffs Will Stay as U.S. Shifts to Producer Economy
The Trump administration is not backing down from its America First trade agenda, and Congress has granted the executive branch the authority to use emergency powers to impose tariffs in support of that agenda, U.S. Trade Representative Jamieson Greer told the Senate Finance Committee in a hearing on Tuesday.
CPA Responds to Chinese Government Sanctions: “We Won’t Be Deterred”
CPA remains unwavering in our commitment to rebuilding U.S. industry and supporting American workers. China’s latest move only proves that our efforts are making an impact—and we will not back down.
America’s Generic Drug Crisis Demands Investment, Not Dependence
The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.
Why the U.S. Needs President Trump’s Tariffs
On April 2, President Donald Trump took bold and historic action to defend American industry with the announcement of sweeping new tariffs aimed at countering unfair foreign trade practices and reigniting U.S. manufacturing. Dubbed “Liberation Day”, this policy marks the first major step in a new era of economic revitalization—one where the United States refuses to accept the systematic dismantling of its industrial base and begins to chart a path back to true production-led prosperity.
CPA Applauds President Trump’s “Liberation Day” Tariff Announcement as Essential Reset of Global Trade System
The Trump administration’s decision to impose a permanent 10% baseline tariff on imports from all countries, combined strategically with higher reciprocal tariffs on nations engaging in unfair trade practices, marks a crucial step forward in reindustrializing America and restoring economic strength and security.
